Ulrich Rumenapp

Ahead of the conference, we launched a delegate survey to gather insights on what participants hoped to gain from the three-day event, as well as the key challenges currently facing pharma contract manufacturing. The survey explored critical topics such as supply chain disruptions, the impact of geopolitical tensions, and the ongoing debate between localisation and centralisation.

In this session, our Advisory Board will review the survey findings, address delegates’ most pressing concerns, and facilitate an open discussion on the issues that matter most to those in the room. 

As the biopharmaceutical landscape grows increasingly complex and competitive, strategic outsourcing has become a vital lever for success. This session explores how to effectively plan, execute, and manage outsourcing in Chemistry, Manufacturing, and Controls development and bio-manufacturing operations.

Attendees will gain actionable insights into building resilient partnerships with CDMOs and balancing internal versus external capabilities to optimise resources, timelines, and quality. Key Discussion Topics:

• Creating a sustainable outsourcing strategy: Aligning business objectives with long-term CDMO partnerships.
• When to outsource and when to stay in-house: Decision frameworks to determine the right balance for your organisation
• Navigating partner selection and contracting challenges: Best practices for due diligence, IP protection, and defining success metrics.
• Building high-performing collaborations: Establishing trust, transparency, and joint governance structures to maximise efficiency and outcomes.
• Bridging cultural and operational gaps: Understanding differing organisational needs and perspectives to foster alignment and shared success.